Why Become a Partner
Partnering with the 6th Gene Therapy Analytical Development Summit Europe gives you exclusive access to an audience actively seeking collaboration with technology solution providers. As the only industry-focused event tailored for a European audience, it attracts biotech and pharma companies eager to advance their gene therapy analytics and regulatory strategies.
These decision-makers are specifically looking for cutting-edge solutions and partnerships to address complex challenges in analytical development, regulatory compliance, and drug product consistency. By partnering with this event, you position your brand as a key player, helping shape the future of gene therapy while forging valuable, collaborative relationships.
What Our Experts Need from You:
Analytical Techniques & Methods: NGS and associated techniques / ddPCR, dPCR, PCR / high-throughput sequencing, mass spectrometry, HPLC, cryoTEM, ELISA
Characterisation & Assay Development: Potency assay development / AAV capsid characterisation / flow cytometry, transmission electron microscopy, bio-layer interferometry
Regulatory & Compliance: IND filing and regulatory alignment / quality control strategies (early to late-stage compliance)
Service Providers & CROs/CDMOs: Assay providers / CROs and CDMOs
Technology & Data Integration: Data management and integration / software solutions for analytical development
Innovation & Automation: Automation and process analytical technologies (PAT) / artificial intelligence and machine learning in analytics
Why Partner in 2025?
Raise your brand awareness in 2025 by positioning yourself in front of key biotech and pharma gene therapy leaders who are actively seeking solutions to their analytical and QC bottlenecks.
Network with industry experts during 8+ hours of dedicated networking sessions and distinguish yourself from competitors in a highly targeted environment.
Generate prospective commercial opportunities with biopharma professionals this May as the community searches for partners to streamline, standardise, and enhance the quality and safety of their assays and gene therapies.
Who Will You Meet?
Current Partners:
